What Sila Realty Trust’s latest acquisition could mean for investors

Sila Realty Trust (SILA) has agreed to acquire a US$43.1 million inpatient rehabilitation facility in Oklahoma City, a 58 bed property that is fully leased under a long term absolute net lease.

The Nobis OKC Facility, recently expanded by 18 beds and about 9,100 square feet to roughly 53,100 square feet, fits the company’s focus on healthcare real estate and may interest investors watching income oriented REITs.

At a share price of US$23.97, Sila Realty Trust has a 7 day share price return of 2.79% and a year to date share price return of 2.00%. The 1 year total shareholder return stands at 5.58%, indicating moderate recent momentum as the company adds income producing healthcare assets like the Nobis OKC Facility.

If this kind of focused healthcare exposure interests you, it may be a useful time to review what is available across healthcare stocks to see what might align with your portfolio goals.

With Sila trading at US$23.97 and sitting at a discount to both one assessment of intrinsic value and the current analyst price target, you have to ask: is this a mispriced healthcare REIT, or is the market already baking in future growth?

Most Popular Narrative: 19.1% Undervalued

With Sila Realty Trust last closing at US$23.97, the most followed narrative pegs fair value closer to US$29.63. This frames today’s price as a discount that depends on specific growth and margin expectations playing out over time.

Sila Realty Trust is benefitting from structural tailwinds related to the growing demand for healthcare facilities from the "aging adult" demographic and the increasing focus on necessity based outpatient and post acute care. This underpins stable long term occupancy and predictable revenue from long lease terms with annual rent escalators that are described as supporting both revenue growth and margin stability.

Curious what sits behind that higher fair value? The narrative leans on steady revenue gains, firmer margins, and a premium earnings multiple. Want the full picture?

Those projections rely on revenue and earnings increasing over several years, profit margins edging higher, and Sila continuing to trade on a relatively rich P/E compared with the broader US Health Care REITs group, all discounted back using a 7.66% rate to arrive at that US$29.63 figure.

Result: Fair Value of $29.63 (UNDERVALUED)

However, higher interest expenses and tenant credit issues, such as bankruptcies or vacancies, could pressure cash flows and challenge the optimistic growth assumptions behind that valuation.

Build Your Own Sila Realty Trust Narrative

If you see the numbers differently or simply prefer to test your own assumptions, you can build a custom Sila view in just a few minutes: Do it your way.

A great starting point for your Sila Realty Trust research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If Sila has caught your eye, do not stop there, the screener can help you spot other opportunities that fit your style before the crowd does.

• Target potential multibaggers early by scanning these 3532 penny stocks with strong financials that pair smaller market caps with solid financials and room for future business development.
• Tap into growth themes in automation and data by filtering for these 24 AI penny stocks that are already tied to real world applications rather than just hype.
• Focus on price tags that may look appealing by checking these 863 undervalued stocks based on cash flows and see which businesses currently trade below their estimated cash flow value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.